Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miRNAs and radiotherapy response in prostate cancer
Maria Konoshenko, Olga E. Bryzgunova, Pavel P. Laktionov
Andrology (2020) Vol. 9, Iss. 2, pp. 529-545
Open Access | Times Cited: 20

Showing 20 citing articles:

Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle
Xiaoxue Hou, Yuxuan Chang, Yu‐Xin Yue, et al.
Advanced Science (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 39
In Situ Self‐Assembly Supramolecular Antagonist Reinforces Radiotherapy by Inhibiting Tumor Apoptosis Evasion
Xiaoxue Hou, Lijun Yang, Paiyun Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 36
Closed Access | Times Cited: 17
Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer
Ying Liu, Xiang Ao, Guoqiang Ji, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 33
MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer
Alireza Azani, Sima Parvizi Omran, Haniyeh Ghasrsaz, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154618-154618
Closed Access | Times Cited: 9
Approaches for boosting antitumor immunity in prostate cancer therapy: A comprehensive review on drugs, products, and nanoparticles
Diandian Chen, Yili Hu
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105048-105048
Closed Access | Times Cited: 8
Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies
Rahamat Unissa Syed, Maali D. Alshammari, Humera Banu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7421-7437
Closed Access | Times Cited: 2
MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome
Shahram Taeb, Davoud Rostamzadeh, Seyed Mohammad Amini, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Docetaxel Resistance in Castration-Resistant Prostate Cancer: Transcriptomic Determinants and the Effect of Inhibiting Wnt/β-Catenin Signaling by XAV939
Elena A. Pudova, Anastasiya A. Kobelyatskaya, И. В. Катунина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12837-12837
Open Access | Times Cited: 10
The Roles of Non-Coding RNAs in Radiotherapy of Gastrointestinal Carcinoma
Jie Li, Juan Sun, Zhen Liu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 8
Exosome‑delivered miR‑486‑3p inhibits the progression of osteosarcoma via sponging CircKEAP1/MARCH1 axis components
Huidong Yang, Cheng He, Yi Feng, et al.
Oncology Letters (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 4
From molecular mechanisms of prostate cancer to translational applications: based on multi-omics fusion analysis and intelligent medicine
Shumin Ren, Jiakun Li, Julián Dorado, et al.
Health Information Science and Systems (2023) Vol. 12, Iss. 1
Closed Access | Times Cited: 4
Extracellular Vesicles-Mediated Transfer of miRNA Let-7b from PC3 Cells to Macrophages
Egidia Costanzi, Rita Romani, Paolo Scarpelli, et al.
Genes (2020) Vol. 11, Iss. 12, pp. 1495-1495
Open Access | Times Cited: 11
The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors
Maria Konoshenko, Pavel P. Laktionov
Andrology (2021) Vol. 10, Iss. 1, pp. 51-71
Open Access | Times Cited: 10
miRNAs in radiotherapy resistance of cancer; a comprehensive review
Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Farag M. A. Altalbawy, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1665-1679
Closed Access | Times Cited: 1
Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients
Dechao Feng, Li Li, Xu Shi, et al.
Aging (2023) Vol. 15, Iss. 18, pp. 9358-9376
Open Access | Times Cited: 3
Combination of multiple omics techniques for a personalized therapy or treatment selection
Chiara Massa, Barbara Seliger
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Prostate cancer therapy outcome prediction: are miRNAs a suitable guide for therapeutic decisions?
Maria Konoshenko, Pavel P. Laktionov, Olga E. Bryzgunova
Andrology (2023) Vol. 12, Iss. 4, pp. 705-718
Open Access | Times Cited: 1
Expression of microRNAs following radiation therapy and association with severity of radiotherapy‑induced toxicity among patients with prostate adenocarcinoma: A systematic review and meta‑analysis
Jagtar Singh, Thanuja Thachil, Sema Mısır, et al.
World Academy of Sciences Journal (2024) Vol. 6, Iss. 3
Open Access
Circ_0006220 (circ-TADA2A) accelerates prostate cancer cell malignant behaviors through miR-520f-3p/CDCA7 axis
Zijin Wan, Gang Liu
Cellular and Molecular Biology (2024) Vol. 70, Iss. 7, pp. 85-91
Closed Access
microRNA profiling of Iraqi patients with gastric cancer
Mohanad Hasan, Reza Safaralizadeh, Mohammad Khalaj‐Kondori
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top